The abstract is read at the publisher; the summary is JClub's.
β-glucan treatment in a mouse necrotizing enterocolitis model rescues NEC-induced long-term cognitive impairment, with similar benefits at low and high doses.
- Why it matters: NEC is common in preterm infants and survivors often have persistent cognitive deficits, yet targeted therapies and gut–brain mechanisms remain unclear.
- What they did: In mice, β-glucan was tested in a NEC model and evaluated by behavior plus multi-omics; it reversed gut microbiota dysbiosis and restored tryptophan metabolism by elevating indole-3-acetic acid (IAA). Fecal microbiota transplantation and exogenous IAA supplementation reproduced β-glucan’s neuroprotective effects, and IAA acted through AHR/MAP2K3/p38 signaling.
- The result: β-glucan and IAA reduced excessive hippocampal microglial activation and neuroinflammation and repaired synaptic ultrastructure and plasticity, supporting a gut microbiota–tryptophan–IAA–AHR/MAP2K3/p38 gut–brain axis.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.